Xencor (XNCR) Non Operating Interest Expenses (2013 - 2026)
Powered by 
Analysis
Xencor (XNCR) Non Operating Interest Expenses (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.56 Bn | 58.37 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.22 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.18 Bn | 44.18 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.31 Bn | 32.00 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Xencor | 2.02 Bn | 1.64 Bn | - | 7.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.35 Mn |
| Mar 31, 2026 | 4.70 Mn |
| Dec 31, 2025 | 7.35 Mn |
| Sep 30, 2025 | 7.67 Mn |
| Jun 30, 2025 | 8.24 Mn |
| Mar 31, 2025 | 8.67 Mn |
| Dec 31, 2024 | 8.66 Mn |
| Sep 30, 2024 | 9.03 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Mar 31, 2024 | 9.68 Mn |
| Dec 31, 2023 | 6.16 Mn |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Jun 30, 2018 | 3,000.00 |
| Mar 31, 2018 | 4,000.00 |
| Dec 31, 2017 | 5,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | 3,000.00 |
| Mar 31, 2017 | 3,000.00 |